| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.046 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |